Sam Brusco, Associate Editor04.20.21
Conformis began a licensing agreement with Paragon 28, which gives Paragon 28 non-exclusive license under Conformis patents for patient-specific instruments with off-the-shelf implants in Paragon 28’s APEX 3D total ankle implant.
“We are pleased to reach this agreement with Paragon 28, enabling it to incorporate our patient-specific instrument technology in its anticipated total ankle replacement offering,” Mark Augusti, Conformis president and CEO told the press. “We believe that this latest license agreement further demonstrates the broad applicability and clinical appeal of Conformis’ technology.”
“We are pleased to reach this agreement with Paragon 28, enabling it to incorporate our patient-specific instrument technology in its anticipated total ankle replacement offering,” Mark Augusti, Conformis president and CEO told the press. “We believe that this latest license agreement further demonstrates the broad applicability and clinical appeal of Conformis’ technology.”